1. Home
  2. SPCB vs GBIO Comparison

SPCB vs GBIO Comparison

Compare SPCB & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • GBIO
  • Stock Information
  • Founded
  • SPCB 1988
  • GBIO 2016
  • Country
  • SPCB Israel
  • GBIO United States
  • Employees
  • SPCB N/A
  • GBIO N/A
  • Industry
  • SPCB Semiconductors
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • GBIO Health Care
  • Exchange
  • SPCB Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • SPCB 21.1M
  • GBIO 23.2M
  • IPO Year
  • SPCB N/A
  • GBIO 2020
  • Fundamental
  • Price
  • SPCB $7.08
  • GBIO $0.45
  • Analyst Decision
  • SPCB Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • SPCB 1
  • GBIO 4
  • Target Price
  • SPCB $18.00
  • GBIO $7.33
  • AVG Volume (30 Days)
  • SPCB 98.6K
  • GBIO 571.4K
  • Earning Date
  • SPCB 05-14-2025
  • GBIO 05-12-2025
  • Dividend Yield
  • SPCB N/A
  • GBIO N/A
  • EPS Growth
  • SPCB N/A
  • GBIO N/A
  • EPS
  • SPCB 1.02
  • GBIO N/A
  • Revenue
  • SPCB $26,843,000.00
  • GBIO $19,892,000.00
  • Revenue This Year
  • SPCB $6.72
  • GBIO N/A
  • Revenue Next Year
  • SPCB $16.91
  • GBIO $10.90
  • P/E Ratio
  • SPCB $6.82
  • GBIO N/A
  • Revenue Growth
  • SPCB 5.23
  • GBIO 236.92
  • 52 Week Low
  • SPCB $2.55
  • GBIO $0.32
  • 52 Week High
  • SPCB $18.95
  • GBIO $4.34
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 54.20
  • GBIO 52.81
  • Support Level
  • SPCB $6.05
  • GBIO $0.34
  • Resistance Level
  • SPCB $6.68
  • GBIO $0.46
  • Average True Range (ATR)
  • SPCB 0.71
  • GBIO 0.05
  • MACD
  • SPCB 0.20
  • GBIO 0.02
  • Stochastic Oscillator
  • SPCB 90.58
  • GBIO 93.33

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: